Moov Gel 1% w/w

Moov Gel is a topical analgesic containing Diclofenac Sodium 1% w/w, manufactured by Astra Biopharmaceuticals Ltd. Priced at ৳60.00 per tube, this NSAID gel effectively reduces inflammation and pain in conditions like arthritis, sports injuries, and musculoskeletal disorders.

This Gel formulation ensures targeted relief by inhibiting prostaglandin synthesis. It treats rheumatoid arthritis, gout, sprains, dental pain, and post-surgical inflammation. Apply 3-4 times daily on affected areas. Avoid contact with eyes or open wounds.

Key benefits include rapid absorption and minimal systemic side effects compared to oral NSAIDs. Store below 30°C. Common side effects may include mild skin irritation or redness. Not recommended during pregnancy without medical advice.

Moov Gel shows drug interactions with anticoagulants, lithium, and methotrexate. Consult doctors before combining with other NSAIDs. Ideal for patients seeking localized pain management without frequent oral medication.

As a cost-effective Diclofenac Sodium alternative, Moov Gel offers versatile applications across orthopedics, gynecology, and dentistry. Its non-greasy texture makes it suitable for daily use while maintaining therapeutic efficacy.

Gel: Apply 2-4g 3-4x daily. Tablet: 75-150 mg/day in divided doses. Adjustments: Reduce dose in elderly. Clean area before applying gel.

Moov is generally well tolerated. Adverse effects are mild, rare and transient. At the starting of the treatment, however, patients may be sometimes complaining of epigastric pain, eructation, nausea and diarrhea or dizziness or headache. These effects are usually mild in nature. Peripheral edema and skin reactions, such as rash and eczema have also been encountered. Moov Gel may cause local irritation and reddening of the skin and skin rash.

Pregnancy: Category D in third trimester. Lactation: Use cautiously. Advice: Avoid prolonged use during breastfeeding.

General: Monitor liver enzymes. Special: CV risk assessment in cardiac patients. Follow Astra Biopharmaceuticals recommended dosage.

Geriatric: Start with 50% dose. Renal: Avoid if CrCl <30. Hepatic: Contraindicated in severe impairment.